71 results
Page 2 of 4
8-K
EX-2.1
umih52 oe
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
8-K
EX-10.1
vcda8kfvfrsu44dg7
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
8-K
EX-99.2
8due 5dmz5
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
424B5
3gpwd
14 Jul 21
Prospectus supplement for primary offering
4:16pm
8-K
EX-1.1
9w0cd
14 Jul 21
Imara Announces Launch of Proposed Public Offering
9:19am
424B5
klurn
13 Jul 21
Prospectus supplement for primary offering
4:20pm
8-K
EX-99.1
g4960w
13 Jul 21
Other Events
4:07pm
DEF 14A
hciydb3ug0zwf7nfj
18 May 21
Definitive proxy
4:06pm
10-K
xepmf
5 Mar 21
Annual report
7:26am
8-K
6wfm3vb2fb
23 Apr 20
Industry leader with global clinical development expertise to help guide Imara’s clinical advancement
7:15am
8-K
EX-3.2
75mxmzcn 5qs7
16 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
EX-3.1
jtkddj7v3fwqcf2myus
16 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:06pm
424B4
bqueo2pwwoo0
12 Mar 20
Prospectus supplement with pricing info
4:03pm
S-1/A
EX-10.1
jcn51gshr
3 Mar 20
IPO registration (amended)
6:13am